Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMN AMN Healthcare Services	$18.89 +7.1%	$20.32	$14.86 ▼ $54.01	$721.95M	0.1	875,521 shs	507,966 shs
BAX Baxter International	$24.16 +0.8%	$28.52	$21.33 ▼ $40.49	$12.42B	0.59	5.24 million shs	2.25 million shs
DVA DaVita	$135.38 +2.5%	$139.84	$126.07 ▼ $179.60	$9.67B	1.09	867,248 shs	170,100 shs
EW Edwards Lifesciences	$77.75 +1.1%	$77.11	$64.00 ▼ $83.00	$45.59B	1.08	4.51 million shs	1.23 million shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMN AMN Healthcare Services	+7.78%	+1.34%	-16.23%	-18.72%	-67.25%
BAX Baxter International	+2.02%	+4.79%	-16.60%	-20.84%	-35.13%
DVA DaVita	+2.22%	-6.31%	-7.27%	-5.72%	-8.03%
EW Edwards Lifesciences	-1.64%	-2.86%	-1.43%	-0.12%	+17.39%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMN AMN Healthcare Services	4.2057 of 5 stars	3.1	2.0	0.0	4.3	1.9	1.7	1.9
BAX Baxter International	4.8192 of 5 stars	4.1	2.0	1.7	4.0	2.3	1.7	2.5
DVA DaVita	4.5408 of 5 stars	2.0	2.0	0.0	4.5	2.0	2.5	4.4
EW Edwards Lifesciences	4.8411 of 5 stars	3.3	4.0	0.0	4.0	3.9	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMN AMN Healthcare Services	2.25	Hold	$28.25	49.55% Upside
BAX Baxter International	2.20	Hold	$30.11	24.61% Upside
DVA DaVita	2.00	Hold	$164.00	21.14% Upside
EW Edwards Lifesciences	2.65	Moderate Buy	$85.90	10.49% Upside

Current Analyst Ratings Breakdown

Latest BAX, AMN, DVA, and EW Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/12/2025	AMN AMN Healthcare Services	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$33.00 ➝ $22.00
8/11/2025	AMN AMN Healthcare Services	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform ➝ Outperform	$27.00 ➝ $22.00
8/8/2025	DVA DaVita	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$148.00
8/7/2025	DVA DaVita	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$169.00 ➝ $160.00
8/7/2025	EW Edwards Lifesciences	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$84.00 ➝ $88.00
8/4/2025	BAX Baxter International	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$41.00 ➝ $36.00
8/4/2025	BAX Baxter International	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$35.00 ➝ $24.00
8/4/2025	BAX Baxter International	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$36.00 ➝ $25.00
8/1/2025	BAX Baxter International	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$33.00 ➝ $24.00
8/1/2025	BAX Baxter International	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$25.00
7/29/2025	EW Edwards Lifesciences	Daiwa America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy

(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMN AMN Healthcare Services	$2.98B	0.24	$15.74 per share	1.20	$15.85 per share	1.19
BAX Baxter International	$10.64B	1.17	$4.89 per share	4.94	$14.20 per share	1.70
DVA DaVita	$12.82B	0.76	$20.09 per share	6.74	($1.51) per share	-89.66
EW Edwards Lifesciences	$5.69B	8.03	$2.72 per share	28.63	$18.07 per share	4.30

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMN AMN Healthcare Services	-$146.98M	-$7.77	N/A	7.81	N/A	-10.75%	11.09%	3.34%	N/A
BAX Baxter International	-$649M	-$0.30	N/A	8.85	0.76	-1.42%	16.96%	5.24%	N/A
DVA DaVita	$936.34M	$10.17	13.29	10.65	0.92	6.35%	369.39%	4.62%	N/A
EW Edwards Lifesciences	$4.17B	$6.95	11.17	28.27	3.77	72.96%	15.01%	11.56%	10/23/2025 (Estimated)

Latest BAX, AMN, DVA, and EW Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	AMN AMN Healthcare Services	$0.17	$0.30	+$0.13	-$3.02	$652.89 million	$658.18 million
8/5/2025	Q2 2025	DVA DaVita	$2.70	$2.95	+$0.25	$2.58	$3.36 billion	$3.38 billion
7/31/2025	Q2 2025	BAX Baxter International	$0.60	$0.59	-$0.01	$0.18	$2.82 billion	$2.81 billion
7/24/2025	Q2 2025	EW Edwards Lifesciences	$0.62	$0.67	+$0.05	$0.56	$1.49 billion	$1.53 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMN AMN Healthcare Services	N/A	N/A	N/A	N/A	N/A
BAX Baxter International	$0.68	2.81%	N/A	N/A	N/A
DVA DaVita	N/A	N/A	N/A	N/A	N/A
EW Edwards Lifesciences	N/A	N/A	N/A	N/A	N/A

Latest BAX, AMN, DVA, and EW Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/14/2025	BAX Baxter International	quarterly	$0.17	2.38%	8/29/2025	8/29/2025	10/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMN AMN Healthcare Services	1.51	1.00	1.08
BAX Baxter International	1.30	2.30	1.49
DVA DaVita	23.18	1.39	1.34
EW Edwards Lifesciences	0.06	4.68	3.87

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMN AMN Healthcare Services	99.23%
BAX Baxter International	90.19%
DVA DaVita	90.12%
EW Edwards Lifesciences	79.46%

Insider Ownership

Company	Insider Ownership
AMN AMN Healthcare Services	0.93%
BAX Baxter International	0.20%
DVA DaVita	1.50%
EW Edwards Lifesciences	0.34%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMN AMN Healthcare Services	2,968	38.32 million	37.93 million	Optionable
BAX Baxter International	38,000	513.62 million	512.59 million	Optionable
DVA DaVita	76,000	71.50 million	70.43 million	Optionable
EW Edwards Lifesciences	15,800	587.10 million	585.10 million	Optionable

BAX, AMN, DVA, and EW Headlines

Recent News About These Companies

Edwards Lifesciences Corporation (NYSE:EW) Holdings Lowered by Rathbones Group PLC

August 13 at 6:54 AM | marketbeat.com

Invesco Ltd. Raises Position in Edwards Lifesciences Corporation (NYSE:EW)

August 13 at 4:49 AM | marketbeat.com

Edwards Lifesciences Corporation (NYSE:EW) Shares Sold by AIA Group Ltd

August 12 at 7:45 AM | marketbeat.com

Nuveen LLC Makes New $330.88 Million Investment in Edwards Lifesciences Corporation (NYSE:EW)

August 12 at 6:16 AM | marketbeat.com

Mizuho Securities USA LLC Decreases Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW)

August 12 at 5:36 AM | marketbeat.com

Aigen Investment Management LP Makes New $1.75 Million Investment in Edwards Lifesciences Corporation (NYSE:EW)

August 11 at 7:32 AM | marketbeat.com

Edwards Lifesciences Corporation (NYSE:EW) Shares Sold by Forsta AP Fonden

August 11 at 6:22 AM | marketbeat.com

National Bank of Canada FI Buys 209,144 Shares of Edwards Lifesciences Corporation (NYSE:EW)

August 11 at 6:22 AM | marketbeat.com

Swiss National Bank Decreases Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW)

August 11 at 6:21 AM | marketbeat.com

Ontario Teachers Pension Plan Board Sells 13,535 Shares of Edwards Lifesciences Corporation (NYSE:EW)

August 11 at 6:04 AM | marketbeat.com

Mitsubishi UFJ Asset Management Co. Ltd. Acquires 95,750 Shares of Edwards Lifesciences Corporation (NYSE:EW)

August 10 at 5:19 AM | marketbeat.com

Maryland State Retirement & Pension System Lowers Position in Edwards Lifesciences Corporation (NYSE:EW)

August 10 at 5:19 AM | marketbeat.com

Edwards Lifesciences Corporation (NYSE:EW) Shares Bought by Charles Schwab Investment Management Inc.

August 10 at 4:46 AM | marketbeat.com

Caisse Des Depots ET Consignations Sells 4,021 Shares of Edwards Lifesciences Corporation (NYSE:EW)

August 9, 2025 | marketbeat.com

Fayez Sarofim & Co Sells 3,278 Shares of Edwards Lifesciences Corporation (NYSE:EW)

August 9, 2025 | marketbeat.com

Edwards Lifesciences Corporation (NYSE:EW) Shares Bought by Vanguard Group Inc.

August 9, 2025 | marketbeat.com

Edwards Lifesciences (NYSE:EW) Price Target Raised to $88.00

August 8, 2025 | marketbeat.com

Edwards Lifesciences Corporation (NYSE:EW) Stock Position Lowered by Deutsche Bank AG

August 8, 2025 | marketbeat.com

ASR Vermogensbeheer N.V. Purchases New Stake in Edwards Lifesciences Corporation (NYSE:EW)

August 8, 2025 | marketbeat.com

Primecap Management Co. CA Has $166.68 Million Stock Position in Edwards Lifesciences Corporation (NYSE:EW)

August 7, 2025 | marketbeat.com

Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight

August 6, 2025 | gurufocus.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BAX, AMN, DVA, and EW Company Descriptions

AMN Healthcare Services NYSE:AMN

$18.89 +1.25 (+7.09%)

As of 12:25 PM Eastern

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.

Baxter International NYSE:BAX

$24.16 +0.18 (+0.77%)

As of 12:25 PM Eastern

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

DaVita NYSE:DVA

$135.38 +3.30 (+2.50%)

As of 12:25 PM Eastern

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Edwards Lifesciences NYSE:EW

$77.75 +0.82 (+1.07%)

As of 12:25 PM Eastern

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time